Drug Type Small molecule drug |
Synonyms LD 09163, LD09163 |
Target |
Action inhibitors |
Mechanism TRPA1 inhibitors(Transient receptor potential cation channel subfamily A member 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammatory Bowel Diseases | IND Approval | United States | 11 May 2024 | |
| Colitis, Ulcerative | Preclinical | China | - | |
| Crohn Disease | Preclinical | China | - |





